Table 5 Comorbidity information of patients with a positive SARS-CoV-2 result during the Founder variant wave (n = 2319 SARS-CoV-2 infections) expressed as frequency percentage.
From: The effect of SARS-CoV-2 variant on respiratory features and mortality
Condition | Fully vaccinated (%) | Partially vaccinated (%) | Unvaccinated (%) |
|---|---|---|---|
AIDS | – | – | 1.63 |
Anemia | – | – | 9.16 |
Anxiety/depression | – | – | 43.38 |
Asthma | – | – | 7.24 |
Atrial fibrillation | – | – | 9.29 |
COPD | – | – | 3.26 |
Cancer | – | – | 5.59 |
Cardiomyopathy | – | – | 5.59 |
Dementia | – | – | 1.16 |
GERD | – | – | 3.34 |
Heart failure | – | – | 21.92 |
Hyperlipidemia | – | – | 14.04 |
Hypertension | – | – | 28.52 |
Immunocompromised | – | – | 2.87 |
Kidney disease | – | – | 34.3 |
Liver disease | – | – | 2.74 |
Myocardial infarction | – | – | 0 |
Obesity | – | – | 20.04 |
Peripheral vascular disease | – | – | 1.71 |
Rheumatoid arthritis | – | – | 1.03 |
SLE | – | – | 0.6 |
Transient ischemic attack | – | – | 0.04 |
Transplant | – | – | 1.71 |
Type 1 diabetes mellitus | – | – | 0.6 |
Type 2 diabetes mellitus | – | – | 26.72 |
